Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2018 Mar 28;17(6):1315–1323. doi: 10.1158/1535-7163.MCT-17-0901

Table 3.

HSP27 and LC3B expression in osteosarcoma specimens

No. of specimens (%)

Factor All Pre-treatment biopsy Primary tumor resection Metastasis resection
HSP27 intensity
 None 41 (16) 9 (16) 28 (21) 4 (6)
 Weak 144 (57) 28 (48) 74 (56) 42 (67)
 Moderate 38 (15) 16 (28) 13 (10) 9 (14)
 Strong 29 (12) 5 (9) 16 (12) 8 (13)
HSP27 percent
 <10% 85 (34) 9 (15) 63 (48) 13 (21)
 ≥10% 168 (66) 50 (85) 68 (52) 50 (79)
LC3B intensity
 None 122 (47) 38 (66) 64 (47) 20 (30)
 Weak 82 (31) 7 (12) 43 (31) 32 (48)
 Moderate 54 (21) 11 (19) 29 (21) 14 (21)
 Strong 3 (1) 2 (3) 1 (1)
LC3B percent
 <10% 128 (49) 38 (66) 68 (50) 22 (33)
 ≥10% 133 (51) 20 (34) 69 (50) 44 (67)